Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.

Frontiers in pediatrics(2023)

Cited 0|Views34
No score
Abstract
In this retrospective cohort of severe MIS-C patients treated with anakinra we report favorable clinical outcomes with a low incidence of side effects. The simultaneous use of steroids ± IVIG in these patients hinders definitive conclusions regarding the need of IL-1 inhibition in MIS-C treatment.
More
Translated text
Key words
anakinra,patients,outcomes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined